Emergency PWAS in Respiratory Infectious Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorThe University of Hong Kong

About this trial

Develop an emergency PanorOmics Wide Association Study (ePWAS) for the early, rapid biological and pathophysiological characterisation of known and novel Infectious Diseases in adult patients presenting to emergency departments with suspected, acute, community-acquired respiratory infectious disease (scaRID).

Phase 1

1. Develop an ED-ID biobank (named ePWAS-RID). Phase 2 2. Targeted research for the discovery of novel diagnostics, prognostics and therapeutics

Eligibility criteria

Qualifiers

Adults ≥18 years of age; AND

Suspected, acute, community-acquired, respiratory, infectious disease (scaRID)*; AND

Informed consent.

Community acquired (not hospitalised for <28 days); AND

Disqualifiers

Refusal of consent;

Recent hospitalisation (<28 days);

Enrolled in another clinical trial

Cellulitis;

Trial design

Treatments tested in this trial

  • Biomarker blood draw and saliva collection

Treatment groups

2,000 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.

Sponsors and collaborators